Literature DB >> 7748881

Neuropsychological development in adolescents: cognitive and emotional model for considering risk factors for adolescents with cleft.

L C Richman1.   

Abstract

This article reviews neurologic, endocrinologic, and neuropsychological developments that affect our understanding of the adolescent patient. Neuroimaging and neuroradiologic techniques have assisted in identifying brain-behavior relationships and how different neuropsychological patterns result in different ways of thinking. Psychoneuroendocrinologic studies have shown that sex differences in maturation and hormonal effects on behavior need taking into account. At adolescence, the individual with a cleft or craniofacial condition may be at risk for adjustment problems due to earlier developmental events, which may affect language, behavior, and self-esteem.

Entities:  

Mesh:

Year:  1995        PMID: 7748881     DOI: 10.1597/1545-1569_1995_032_0099_ndiaca_2.3.co_2

Source DB:  PubMed          Journal:  Cleft Palate Craniofac J        ISSN: 1055-6656


  4 in total

1.  Academic achievement of children and adolescents with oral clefts.

Authors:  George L Wehby; Brent Collet; Sheila Barron; Paul A Romitti; Timothy N Ansley; Matthew Speltz
Journal:  Pediatrics       Date:  2014-05       Impact factor: 7.124

Review 2.  Neuropsychological, behavioral, and academic sequelae of cleft: early developmental, school age, and adolescent/young adult outcomes.

Authors:  Lynn C Richman; Thomasin E McCoy; Amy L Conrad; Peg C Nopoulos
Journal:  Cleft Palate Craniofac J       Date:  2011-09-09

3.  Children with oral clefts are at greater risk for persistent low achievement in school than classmates.

Authors:  George L Wehby; Brent R Collett; Sheila Barron; Paul Romitti; Timothy Ansley
Journal:  Arch Dis Child       Date:  2015-09-07       Impact factor: 3.791

4.  Psychotropic drug use in adolescents born with an orofacial cleft: a population-based study.

Authors:  Sofia Nilsson; Juan Merlo; Viveka Lyberg-Åhlander; Elia Psouni
Journal:  BMJ Open       Date:  2015-04-02       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.